Prelude Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Other funds holding ORIC
Prelude Capital Management's ORIC Position: Q3 2026 in Review
Prelude Capital Management sold out of Oric Pharmaceuticals (ORIC) in Q3 2026, closing a stake of 11,300 shares — an estimated $122K sold.
Prelude Capital Management first reported a position in ORIC in Q2 2022 and held it in 6 quarters. The position peaked at $584K in Q1 2026. 203 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.
- Prelude Capital Management reported no remaining Oric Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Prelude Capital Management sold 11,300 Oric Pharmaceuticals shares in Q3 2026, an estimated $122K.
- Prelude Capital Management first reported a position in Oric Pharmaceuticals in Q2 2022 and held it in 6 quarters.
- Prelude Capital Management's Oric Pharmaceuticals position peaked at $584K in Q1 2026.
- 203 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.
Based on Prelude Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.